Mefoglip Tablet

About Mefoglip 5 mg + 500 mg Tablet

Mefoglip comes as a tablet with 5 mg + 500 mg of Glipizide + Metformin Hydrochloride, from Incepta Pharmaceuticals Ltd. It can be started as initial therapy or used as second-line therapy when other treatments have not achieved satisfactory control.

There are 6 brands of Glipizide + Metformin Hydrochloride listed in Bangladesh. The lowest listed price is Mefoglip 2.5 mg + 250 mg Tablet at ৳ 1.9 per unit.

What is Mefoglip 5 mg + 500 mg Tablet?

Mefoglip is a tablet from Incepta Pharmaceuticals Ltd., with the generic name Glipizide + Metformin Hydrochloride. The tablet is taken with meals, and the dose is adjusted gradually. It is used under a doctor's supervision, and the dose is set by the doctor. Use it only as your doctor directs.

Uses of Mefoglip

It can be started as initial therapy or used as second-line therapy when other treatments have not achieved satisfactory control. It is prescribed when diet and exercise alone are not enough, or as a second-line treatment when other initial therapy has not worked. It helps lower both fasting and post-meal blood sugar levels. The doctor decides if this combination is suitable for a particular patient.

How to use Mefoglip

The doctor starts with a low dose and increases it gradually based on blood sugar response. Mefoglip is taken by mouth. Swallow the tablet with water. Take Mefoglip exactly as your doctor prescribes. Do not change the dose or stop taking it without medical advice.

Side effects of Mefoglip

Low blood sugar may cause shakiness, sweating, or confusion. If you experience severe or persistent side effects, contact your doctor. Contact your doctor if you notice anything unusual after taking it. Do not stop taking the medicine without medical advice.

Safety and precautions

It should not be used if you have kidney problems, diabetic coma or ketoacidosis, chronic kidney disease, heart failure, trauma, dehydration, alcohol dependence, or if you are pregnant or breastfeeding. Older adults and those with reduced kidney function need careful dose adjustment. Your doctor will check your kidney function and may stop the medicine before surgery.

Frequently asked questions

What is Mefoglip used for?

It can be started as initial therapy or used as second-line therapy when other treatments have not achieved satisfactory control. It is prescribed when diet and exercise alone are not enough, or as a second-line treatment when other initial therapy has not worked.

How do I use Mefoglip correctly?

The doctor starts with a low dose and increases it gradually based on blood sugar response. Mefoglip is taken by mouth.

Can Mefoglip cause side effects?

Low blood sugar may cause shakiness, sweating, or confusion. If you experience severe or persistent side effects, contact your doctor.

Is Mefoglip safe for everyone?

It should not be used if you have kidney problems, diabetic coma or ketoacidosis, chronic kidney disease, heart failure, trauma, dehydration, alcohol dependence, or if you are pregnant or breastfeeding. Older adults and those with reduced kidney function need careful dose adjustment.

Indications

Glipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment ... Read moreGlipizide & Metformin is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone and as second-line therapy when diet, exercise, and initial treatment with a Sulfonylurea or Metformin do not result in adequate glycemic control in patients with type 2 diabetes

Pharmacology

Metformin is a biguanide antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacological mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylurea, metformin does not produce hypoglycemia in either patient with type 2 diabetes or normal subjects and does not cause hyperinsulinemia.

Glipizide is a sulfonylurea which appears to lower blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Extrapancreatic effects may play a part in the mechanism of action of oral sulfonylurea hypoglycemic drugs.

Dosage & Administration

Glipizide & Metformin should be given once or twice daily with meals and should be initiated at a low dose, with gradual dose escalation.

Glipizide & Metformin as Initial Therapy: The recommended starting dose is 250 mg/2.5 mg once a day with meal.

Glipizide & Metformin as Second-Line Therapy: The recommended starting dose is 500 mg/2.5 mg or 500 mg/5 mg twice daily with the morning and evening meals. The maximum recommended daily dose is 2000 mg Metformin/20 mg Glipizide.

Interaction

Cimetidine reduces the renal clearance of Metformin. Alcohol potentiates the antihyperglycemic & hyperlactataemic effect of Metformin. It may enhance the effects of anti-coagulants. Such patients receiving the two drugs may need adjustment of the anti-coagulant dosage. Nifedipine appears to enhance the absorption of Metformin but Metformin has minimal effects on Nifedipine. The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.

Contraindications

Hypersensitivity to the drug, renal impairment, diabetic coma and ketoacidosis, chronic renal diseases, congestive heart failure, trauma, dehydration, alcohol dependence, pregnancy, breast-feeding etc.

Side Effects

The most common side effects of Glipizide & Metformin are hypoglycemia,
diarrhea, nausea/vomiting, abdominal pain, headache, musculoskeletal pain etc.

Pregnancy & Lactation

Contraindicated during Pregnancy & Lactation

Precautions & Warnings

Metformin is known to be substantially excreted by the kidney, and the risk of Metformin accumulation and lactic acidosis is increased with the degree of impairment of renal function. Thus, patients with serum creatinine levels above the upper limit of normal should not receive Metformin. In patients with advanced age, Metformin should be carefully titrated to establish minimum dose for adequate glycemic control, because aging is associated with reduced renal function. Metformin therapy should be temporarily suspended for any surgical procedure and should not be restarted until the patient’s oral intake has resumed and renal function has been evaluated as normal. During concomitant therapy with sulfonylurea, blood glucose should be monitored. Metformin & insulin therapy should be carried out in hospital until the correct ratio of the two drugs has been established. The metabolism and excretion of Glipizide may be slowed in patients with impaired renal and/or hepatic function. If hypoglycemia should occur in such patients, it may be prolonged and appropriate management should be instituted.

Storage Conditions

Store below 25ºC in a cool and dry place.

Alternative brands of Glipizide + Metformin Hydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.